118 related articles for article (PubMed ID: 37943840)
21. Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis.
Hu X; Wu Y; Yang P; Wang J; Wang P; Cai J
Int Braz J Urol; 2022; 48(6):891-902. PubMed ID: 34003611
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
Hope TA; Eiber M; Armstrong WR; Juarez R; Murthy V; Lawhn-Heath C; Behr SC; Zhang L; Barbato F; Ceci F; Farolfi A; Schwarzenböck SM; Unterrainer M; Zacho HD; Nguyen HG; Cooperberg MR; Carroll PR; Reiter RE; Holden S; Herrmann K; Zhu S; Fendler WP; Czernin J; Calais J
JAMA Oncol; 2021 Nov; 7(11):1635-1642. PubMed ID: 34529005
[TBL] [Abstract][Full Text] [Related]
23. Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy.
Michalski K; Mix M; Meyer PT; Ruf J
Nuklearmedizin; 2019 Dec; 58(6):443-450. PubMed ID: 31724145
[TBL] [Abstract][Full Text] [Related]
24. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
25. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
26. The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy.
Gultekin MH; Demirci E; Turegun FA; Kabasakal L; Sahin OE; Ocak M; Onal B; Erozenci A
Urol J; 2020 Dec; 18(1):58-65. PubMed ID: 33349912
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.
Meijer D; Eppinga WSC; Mohede RM; Vanneste BGL; Meijnen P; Meijer OWM; Daniels LA; van den Bergh RCN; Lont AP; Ettema RH; Oudshoorn FHK; van Leeuwen PJ; van der Poel HG; Donswijk ML; Oprea-Lager DE; Schaake EE; Vis AN
Eur Urol Oncol; 2022 Apr; 5(2):146-152. PubMed ID: 35074282
[TBL] [Abstract][Full Text] [Related]
28. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
Zhao R; Li Y; Nie L; Qin K; Zhang H; Shi H
Medicine (Baltimore); 2021 Apr; 100(15):e25417. PubMed ID: 33847640
[TBL] [Abstract][Full Text] [Related]
29. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of in vivo CAR T cells tracking using streptavidin-biotin-paired positron emission tomography.
Pan D; Wang Y; Xu N; Xu Y; Wang X; Wang L; Yan J; Yu L; Miao L; Wang G; Yang M
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4419-4426. PubMed ID: 35902411
[TBL] [Abstract][Full Text] [Related]
31. Advanced generation anti-prostate specific membrane antigen designer T cells for prostate cancer immunotherapy.
Ma Q; Gomes EM; Lo AS; Junghans RP
Prostate; 2014 Feb; 74(3):286-96. PubMed ID: 24174378
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing Meningioma From Metastasis of Prostate Cancer on 68Ga-PSMA PET/CT.
Filizoglu N; Oksuzoglu K; Ozguven S
Clin Nucl Med; 2021 Nov; 46(11):e553-e555. PubMed ID: 34606488
[TBL] [Abstract][Full Text] [Related]
33. Reduced Acquisition Time per Bed Position for PET/MRI Using
Duan H; Baratto L; Hatami N; Liang T; Levin CS; Khalighi MM; Iagaru A
AJR Am J Roentgenol; 2022 Feb; 218(2):333-340. PubMed ID: 34406051
[No Abstract] [Full Text] [Related]
34. Correlation between Prostate Cancer Positive Cores and 68Ga-PSMA Distribution in Prostate Gland.
Çankaya S; Caylan AE; Aydin F; Uçar M; Kutlu Ö
Urol Int; 2024; 108(1):65-72. PubMed ID: 38016433
[TBL] [Abstract][Full Text] [Related]
35. 68Ga-PSMA PET/CT Scan on Postoperative Assessment of Sinonasal Glomangiopericytoma.
Sakthivel P; Kumar A; Arunraj ST; Singh CA; Kumar R
Clin Nucl Med; 2021 Sep; 46(9):e478-e479. PubMed ID: 33826565
[TBL] [Abstract][Full Text] [Related]
36. Delayed 68Ga-PSMA PET/CT Image-Guided Biopsy for Low-Grade Adenocarcinoma in Benign Prostatic Hyperplasia.
Santhosh S; Jeeva G
Clin Nucl Med; 2021 Apr; 46(4):e190-e192. PubMed ID: 33234940
[TBL] [Abstract][Full Text] [Related]
37. [68Ga]Ga-PSMA-11 PET-CT: Local preliminary experience in prostate cancer biochemical recurrence patients.
Carvalho J; Nunes P; Da Silva ET; Silva R; Lima J; Quaresma V; Figueiredo A
Arch Ital Urol Androl; 2021 Mar; 93(1):21-25. PubMed ID: 33754603
[TBL] [Abstract][Full Text] [Related]
38. Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
Karyağar S; Güven O; Karyağar SS; Arici S; Selvi O; Geredeli Ç; Özülker F
Nucl Med Commun; 2021 Sep; 42(9):1011-1016. PubMed ID: 33958536
[TBL] [Abstract][Full Text] [Related]
39. Fully human antibody V
Wang G; Zhou X; Fucà G; Dukhovlinova E; Shou P; Li H; Johnston C; Mcguinness B; Dotti G; Du H
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795386
[TBL] [Abstract][Full Text] [Related]
40. Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.
Zhang X; Sun S; Miao Y; Yuan Y; Zhao W; Li H; Wei X; Huang C; Hu X; Wang B; Xu H; Zhang W; Gao X; Song J; Zheng J; Zhang Q
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3511-3520. PubMed ID: 35962287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
